电话:
400-7060-959
传真:
+86 10 56315212-8813
电子邮件:
orders@antibodies-online.cn

Recombinant MS4A1 (Rituximab Biosimilar) 抗体

适用: 人 FACS, in vivo 宿主: 小鼠 Monoclonal 10F381 unconjugated Recombinant Antibody
产品编号 ABIN7200660
发货至: 中国
  • 抗原 See all MS4A1 (Rituximab Biosimilar) products
    MS4A1 (Rituximab Biosimilar)
    抗体类型
    Recombinant Antibody
    适用
    • 7
    • 2
    • 2
    宿主
    • 2
    • 2
    • 2
    • 1
    小鼠
    克隆类型
    • 6
    • 1
    单克隆
    标记
    • 7
    This MS4A1 (Rituximab Biosimilar) antibody is un-conjugated
    应用范围
    Flow Cytometry (FACS), In vivo Studies (in vivo)
    原理
    Rituximab Biosimilar, CD20 Monoclonal Antibody
    特异性
    The monoclonal antibody rituximab biosimilar specifically binds to the human TNF alpha.
    产品特性
    Recombinant Humanized IgG1 Monoclonal Antibody.
    纯化方法
    Protein A affinity column
    纯度
    > 95% by SDS-PAGE under reducing conditions and HPLC.
    过滤
    0.2 μm filtered
    内毒素水平
    < 1 EU per 1 mg of the protein by the LAL method.
    免疫原
    The monoclonal antibody rituximab biosimilar was produced in the Rituximab biosimilar CHO stable cell line.
    克隆位点
    10F381
    亚型
    IgG1 kappa
  • 应用备注
    ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by rituximab.
    限制
    仅限研究用
  • 状态
    Liquid
    浓度
    1 mg/mL
    缓冲液
    PBS, pH 7.4, no stabilizers or preservatives.
    储存液
    Without preservative
    注意事项
    Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
    储存条件
    -20 °C
    储存方法
    12 months from date of receipt, -20 to -70°C as supplied. 1 month from date of receipt, 2 to 8°C as supplied.
    有效期
    12 months
  • 抗原
    MS4A1 (Rituximab Biosimilar)
    Abstract
    MS4A1 (Rituximab Biosimilar) 产品
    别名
    B1 antibody, Bp35 antibody, CD20 antibody, CVID5 antibody, LEU-16 antibody, MS4A2 antibody, S7 antibody, membrane spanning 4-domains A1 antibody, MS4A1 antibody
    物质类
    Biosimilar
    背景
    B-lymphocyte antigen CD20 encoded by the MS4A1 gene is an activated-glycosylated phosphoprotein on the surface of all B-cells. The function of the membrane protein is to stimulate B-cell immune response, specifically against T-independent antigens though its natural ligand remains unknown. CD20 is important for the development and differentiation of B-cells into plasma cells. CD20 belongs to the membrane-spanning 4A family with common structural features, similar intron/exon splice boundaries, and unique expression patterns among hematopoietic cells and nonlymphoid tissues.

    Rituximab, a chimeric anti-CD20 monoclonal antibody, destroys B cells and is used to treat diseases with excessive numbers of B cells, overactive B cells, or dysfunctional B cells, such as many lymphomas, leukemias, transplant rejection, and autoimmune disorders.
You are here: